Leucovorin may help with improving verbal communication in certain individuals with ASD who have a vitamin deficiency

If you or a loved one have ASD, please subscribe to our newsletter for the latest updates on this insight and check out our FAQ.

Click the video above to watch a story that ran on CBS Evening News about leucovorin for ASD.

Every Cure is excited to highlight the potential role that leucovorin (folinic acid) may play in improving verbal communication in some individuals with autism spectrum disorder (ASD) who have speech challenges and certain antibodies that cause a vitamin deficiency in the brain. As a nonprofit research organization committed to identifying and elevating potential repurposed treatments, we’ve summarized information about this promising drug repurposing opportunity below. 

A vitamin deficiency may contribute to speech challenges in some individuals with ASD

Research shows that some individuals with ASD who experience speech challenges have a folate (folic acid, a form of vitamin B9) deficiency in the brain. This vitamin deficiency is caused by an autoimmune response where antibodies block folate from entering the brain through the Folate Receptor Alpha (FR⍺). These antibodies can be detected through a blood test that can be ordered by a physician. Though only 5-10% of the general population have these antibodies, research suggests that approximately 50-70% of individuals with ASD have these antibodies. 

A. Typical CNS folate metabolism B. Cerebral folate deficiency in FRAA + ASD C. Correction of folate deficiency in FRAA + ASD

Figure 1. (A) Typical CNS folate metabolism. Folate can cross the blood brain barrier via the FRα in a healthy brain. (B) Cerebral folate deficiency in FRAA+ASD. This process is inhibited in individuals with folate receptor autoantibodies (FRAA) who have a cerebral folate deficiency which affects neuronal functioning. (C) Correction of folate deficiency in FRAA + ASD. Leucovorin treatment can bypass the FRα blockade and enter the brain via the reduced folate channel (RFC) and restore folic acid levels and neuronal functioning in the brain.

Taking a vitamin may help with speech challenges in some individuals with ASD

Leucovorin (folinic acid) is a naturally occurring vitamin derivative of folate that can use an alternative pathway to reach the brain, bypassing the blocked receptor.1 Multiple clinical trials suggest that leucovorin may help correct this deficiency in individuals with ASD who have these antibodies, potentially improving speech and other symptoms.2–4 These trials indicate that leucovorin is most effective in individuals with high levels of these antibodies, but it may also provide benefits for those with low or no detectable antibodies. It is important to note that leucovorin is required to bypass FR⍺ — standard folate or folic acid supplements are unlikely to be helpful. While studies have reported limited side effects, and leucovorin is generally considered safe for long-term use in other conditions (megaloblastic anemia, coadministered with methotrexate and 5-FU), it has not been studied for long-term use in ASD. 

Three randomized controlled trials, performed in the US, France, and India, demonstrated improved verbal communication and other behaviors (daily living skills, irritability, stereotyped behavior and hyperactivity), particularly in individuals with ASD who had the folate- blocking antibodies. Response rates among those receiving leucovorin ranged from 44-56%, compared to 14-20% in the placebo groups:

A wide range of doses were used in these studies with the lowest dose being 5mg twice daily. 

All trials were conducted on children ages 2-15 years old. Further research is underway to better understand this treatment, including a study of 2.5-5 year olds. 

Although there is accumulating evidence regarding these antibodies and the potential benefits of leucovorin, testing for these antibodies remains underutilized, and treatment with leucovorin is not widely implemented. We believe limited utilization of the test and medication is related to limited awareness.

What should I do if I’d like more information for myself or a family member?

If you or a loved one is interested in learning more about this medication, please talk to your doctor. Your doctor can order the antibody test from https://www.fratnow.com/

Everyone with ASD could consider having this test done. A positive test suggests that leucovorin is more likely to help with verbal communication than a negative test. 

As with all FDA-approved medications that could be used “off-label” for a different condition, it is important for physicians and patients to evaluate the potential risks and benefits based on an individual’s needs. 

How can I share my own experiences with leucovorin?

We love hearing from patients and physicians who have experiences with repurposed medicines like leucovorin. You can share your experiences and ideas here: https://everycure.org/ideas/ 

You can also sign up as an “expert” to share your expertise on this repurposed treatment and others: https://everycure.org/experts/ 

Perspectives from Every Cure, Dr Richard Frye, and the Brain Foundation 

Perspective from Every Cure’s Co-Founders:

Replenishing a known vitamin deficiency to address speech challenges in individuals with ASD is a powerful example of data-driven drug repurposing—one that we at Every Cure are excited to highlight and share. Every Cure has built an AI platform to identify and prioritize the most promising drug repurposing opportunities for further research and use in patients. We are committed to advancing knowledge and collaborating to improve access to existing treatments that can help patients in need.

Perspective from the leading researcher, Dr Richard Frye, about the significance of this:

“First, this treatment addresses core symptoms of autism, not just behaviors or medical issues associated with autism. Second, this treatment addresses a key abnormality that might be a root biological mechanism that may promote the development of autism symptoms. This means that this treatment may be fixing the underlying biology which, in turn, may be driving autism symptoms to improve. This would, indeed, be considered a significant medical breakthrough in this field. Third, we obtained these results with leucovorin (folinic acid), a vitamin that is a very well tolerated and considered a safe treatment. Leucovorin has been in clinical use in pediatric oncology since the 1950s to rescue the body from the ill effects of a chemotherapy agent known as methotrexate. So the treatment we are giving has been studied for quite some time and the safety profile is well known. This is in contrast to many common treatments used for children with autism with less well-known safety profiles, which are less well studied, and can lead to adverse effects which can sometimes be serious.” Full interview here: https://www.nofone.org/dr-frye-q-and-a-folinic

For more from Dr. Frye and the Autism Discovery and Treatment Foundation, visit https://drfryemdphd.com/folate/ and https://autismdiscovery.org/.

Perspective from the President of The BRAIN Foundation, Pramila Srinivasan, Ph.D.
“These results are promising and from my experience talking to hundreds of parents of children in our community, anecdotally, some parents report remarkable improvement (particularly those with diagnosed antibodies) and a good number saw moderate improvements. However, no one reported any side effects, so it is definitely worth looking into as an adjunct therapy along with speech and behavioral therapy.”

For more from the BRAIN Foundation, visit  http://www.brainfoundation.org

A note about terminology: Every Cure is committed to respectful and inclusive language that reflects the perspectives of the communities we aim to support. Our goal is to foster meaningful dialogue and collaboration while advancing research that improves lives. We recognize that preferences vary within the autism community, with some individuals preferring identity-first language (e.g., “autistic person”) and others preferring person-first language (e.g., “individual with autism”). Whenever possible, we defer to the preferences of the community and encourage asking individuals or groups how they wish to be addressed. Please contact us at [email protected] if you have any suggestions for how to improve our language.

Medical Disclaimer

The information provided in this post is for educational and informational purposes only and is not intended as medical advice. Every Cure does not provide medical diagnosis, treatment recommendations, or individualized healthcare guidance. If you or a loved one is considering leucovorin (folinic acid) or any other treatment, please consult with a qualified healthcare provider to discuss potential risks, benefits, and suitability based on your individual medical history.  

Any mention of specific tests, treatments, or research studies is for informational purposes and does not constitute an endorsement. The use of FDA-approved medications for conditions not originally approved (off-label use) should be carefully evaluated by a licensed physician.  

References

  1. https://pubmed.ncbi.nlm.nih.gov/34834493/
  2. https://pubmed.ncbi.nlm.nih.gov/27752075/
  3. https://pubmed.ncbi.nlm.nih.gov/39243316/
  4. https://pubmed.ncbi.nlm.nih.gov/32387472/

Frequently Asked Questions (FAQ) About Leucovorin for Autism

1. Is leucovorin a cure for autism?

No. However, some individuals with an autism diagnosis may benefit from Leucovorin. Those that benefit show improvements in verbal communication.

2. How does leucovorin help some individuals with autism?

Research shows that some individuals have a folate (folic acid, a form of vitamin B9) vitamin deficiency in the brain. This is referred to as a Cerebral Folate Deficiency and these individuals often also have an autism diagnosis. Cerebral Folate Deficiency can be caused by an autoimmune response where antibodies block folate from entering the brain through the Folate Receptor Alpha (FR⍺). These antibodies can be detected through a blood test that can be ordered by a physician.

Figure 1. (A) Folate can cross the blood brain barrier via the FRα in a healthy brain. (B) This process is inhibited in individuals with folate receptor autoantibodies (FRAA) who have a cerebral folate deficiency which affects neuronal functioning. (C) Leucovorin treatment can bypass the FRα blockade and enter the brain via the reduced folate channel (RFC) and restore folic acid levels and neuronal functioning in the brain.

Leucovorin (folinic acid) is a naturally occurring vitamin derivative of folate that uses an alternative pathway to reach the brain, bypassing the blocked receptor. Multiple clinical trials suggest that leucovorin may help correct this deficiency in individuals with ASD who have these antibodies, potentially improving speech and other symptoms.1,2,3 These trials indicate that leucovorin is most effective in individuals with high levels of these antibodies, but it may also provide benefits for those with low or no detectable antibodies. It is important to note that leucovorin is required to bypass FR⍺; folate or folic acid supplements are unlikely to be helpful. Leucovorin is generally considered safe for long-term use in other conditions (megaloblastic anemia, coadministered with methotrexate and 5-FU); it has not been studied for long-term use in ASD.

3. What evidence is there to indicate that it works?

Three randomized controlled trials, performed in the US, France, and India, demonstrated improved verbal communication and other behaviors (daily living skills, irritability, stereotyped behavior and hyperactivity), particularly in individuals with ASD who had the folate- blocking antibodies.1,2,3 Response rates among those receiving leucovorin ranged from 44-56%, compared to 14-20% in the placebo groups.

4. What is known about the safety of leucovorin?

There is no one measurement of how safe a drug is, but leucovorin is a naturally occurring vitamin that has been used as a medication in people for decades. A recent meta-analysis concluded that “leucovorin is associated with improvements in core and associated symptoms of ASD and appears safe and generally well-tolerated, with the strongest evidence coming from the blinded, placebo-controlled studies.” It also indicated “significant adverse effects across studies were generally mild but the most common were aggression (9.5%), excitement or agitation (11.7%), headache (4.9%), insomnia (8.5%), and increased tantrums (6.2%).”6

According to Dr. Frye7, most adverse effects tend to resolve with continued use. Children who initially experience increased energy often improve beyond their baseline after a few weeks. If insomnia occurs, it is usually managed by giving the second dose in the afternoon instead of the evening. Because folate is water-soluble and excreted in urine, any lingering effects typically resolve quickly if the medication is stopped.

5. How do I know if leucovorin is right for my child?

The best way to determine if leucovorin could help is to talk to your child’s physician. Some children may be good candidates if they have:

  • A diagnosis of autism
  • Communication difficulties
  • Signs of cerebral folate deficiency:5  Some common symptoms may include agitation, insomnia, slower-than-normal head growth, and delays in movement and coordination, often with low muscle tone and balance issues. Less common signs include stiffness or unusual reflexes in arms and legs, involuntary movements, and/or seizures.

Definitive diagnosis of cerebral folate deficiency involves a lumbar puncture procedure (also referred to as a spinal tap) to test for folate and its derivatives in spinal fluid. However, detection of folate receptor autoantibodies in the blood can be a good intermediate step to see if leucovorin is right for your child. The Folate Receptor Antibody Test (FRAT) is a blood test that checks for the presence of autoantibodies that can block folate from entering the brain. These autoantibodies have been found to be present in a large percentage (50-70%) of children with autism. It is important to note that these antibodies can also be found in 10-15% of children who do not have autism.6 If your child has a positive FRAT, it indicates that leucovorin is more likely to be helpful than if the test is negative. However, leucovorin does not help all children who test positive for FRAT and some children with autism who test negative for FRAT may still experience benefits from leucovorin. If your physician is unfamiliar with leucovorin for autism, you might suggest they consult a specialist in developmental pediatrics or neurology.

6. Is there merit in seeking off-label use of Leucovorin in a pediatric patient even in the absence of FRAA testing?

Folate receptor alpha autoantibodies (FRAAs) can be identified in some children with autism and cerebral folate deficiency, and leucovorin has been shown to help some children who test positive.4 However, leucovorin does not help all children who test positive for FRAAs, and some children with autism who have not been tested—or who test negative for FRAAs—may still experience benefits from leucovorin. There is more to understand in regards to who may benefit from leucovorin treatment. If FRAA testing is unavailable, discussing leucovorin with your child’s doctor as an off-label treatment option even without testing results may still be worthwhile (see question 4 for more information on the safety profile of leucovorin). As with all treatment decisions, you should speak with your child’s doctor to determine if the likely benefits may outweigh the risks and it might be a good fit.

7. Can a doctor prescribe leucovorin for autism even though it is not approved for autism?

As with all FDA-approved medications that could be used “off-label” for a different condition, it is important for physicians and patients to evaluate the potential risks and benefits based on an individual’s needs.

8. Could Leucovorin help older children with autism?

Available studies have primarily focused on younger children (ages 2-14) and have shown benefits particularly in areas such as verbal communication, social engagement, and attention.1,2,3 Available research suggests that earlier intervention may lead to better outcomes. Further research is underway to better understand this treatment in various age populations. If you are considering leucovorin for your child, speak with your child’s doctor to determine if the likely benefits may outweigh the risks and it might be a good fit.

9. What is the recommended dosage of this treatment?

The dosage of leucovorin that was used in the three randomized controlled trials to date varied widely. A commonly used dose is 2 mg/kg per day (maximum 50 mg per day), typically given in two divided doses. Individuals are often started at a lower dose, for example 5 mg twice daily (regardless of age and weight), and the dose is increased over a period of time.6 The right dosage for your child should be determined by their doctor.

10. How can my child be enrolled in ongoing research or trials being done by Every Cure on autism and leucovorin?

Every Cure is not currently running clinical trials on leucovorin for autism. You may find clinical trials by checking ClinicalTrials.gov or reaching out to autism research organizations. If new studies become available, we will update this information.

11. Can you provide a list of physicians who perform Folate Receptor Antibody Testing (FRAT) in my area and/or that prescribe leucovorin?

Every Cure does not maintain a list of providers who offer FRAT and/or prescribe leucovorin. Some physicians may be more familiar with this test and/or prescribing leucovorin than others– developmental pediatricians, Medical Academy for Pediatric Special Needs (MAPS) doctors, and neurologists specializing in autism may be more familiar with the test. Sharing information with your child’s doctor about research on leucovorin and its potential benefits for autism could help them make a decision about testing.

12. Is folinic acid (leucovorin) the same as folic acid?

No, folinic acid (leucovorin) and folic acid are different.

Folinic acid (leucovorin) is an active form of folate that can bypass certain antibody blockers present in some individuals and cross into the brain efficiently.

Folic acid is a synthetic form of folate that is not able to bypass certain antibody blockers present in some individuals and cannot readily cross into the brain.

13. How can I share my own experiences with leucovorin?

We love hearing from individuals, care givers, and physicians who have experiences with repurposed medicines like leucovorin. You can share your experiences by emailing [email protected]

You can also sign up as an Expert to share your expertise on this repurposed treatment and others: https://everycure.org/experts/ 

14. I feel like I’ve heard about this in the news. Can you share those articles and stories?

15. What should I do if I’d like more information for myself or a family member?

If you or a loved one is interested in learning more about this medication, please talk to your doctor. Your doctor can order the antibody test from https://www.fratnow.com/

Everyone with ASD could consider having this test done. A positive test suggests that leucovorin is more likely to help with verbal communication than a negative test.

References

  1. Frye RE, Slattery JC, Delhey LM, et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2018;23(2):247-256. doi:10.1038/mp.2016.168
  2. Panda PK, Sharawat IK, Saha S, et al. Efficacy of oral folinic acid supplementation in children with autism spectrum disorder: a randomized double-blind, placebo-controlled trial. Eur J Pediatr. 2024;183(12):4827-4835. doi:10.1007/s00431-024-05762-6
  3. Renard E, Leheup B, Guéant-Rodriguez R-M, et al. Folinic acid improves the score of autism in the EFFET placebo-controlled randomized trial. Biochimie. 2020;173:57-61. doi:10.1016/j.biochi.2020.04.019
  4. Bobrowski-Khoury N, Ramaekers VT, Sequeira JM, Quadros EV. Folate receptor alpha autoantibodies in autism spectrum disorders: diagnosis, treatment and prevention. J Pers Med. 2021;11(8):710. doi:10.3390/jpm11080710
  5. Ramaekers VT, Quadros EV. Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies. Nutrients. 2022; 14(15):3096. https://doi.org/10.3390/nu14153096
  6. Rossignol DA, Frye RE. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 2021; 11(11):1141. https://doi.org/10.3390/jpm11111141
  7. Frye RE. The Folate Fix: Exploring the Role of Folate in Autism and Neurodevelopmental Disorders. Metabolic Learning Resource, LLC; 2025.

 

Arrow Shape Facebook Instagram Twitter Youtube Play Arrow Left